Histological Evaluation of Leukoplakia following CO2 Laser Excision

Author(s):  
Bernd Fleiner ◽  
Thomas Plath
2010 ◽  
Vol 28 (S2) ◽  
pp. S-115-S-119 ◽  
Author(s):  
Lyndsay Fraser ◽  
Gerard Kelly ◽  
Kenneth MacLennan ◽  
Zvoru G.G. Makura

1990 ◽  
Vol 8 (5) ◽  
pp. 77-78 ◽  
Author(s):  
C.A. Van Hasselt ◽  
John Waldron ◽  
J.A.S. Carruth

1986 ◽  
Vol 6 (2) ◽  
pp. 103-105 ◽  
Author(s):  
Raymond J. Lanzafame ◽  
David W. Rogers ◽  
John O. Naim ◽  
H. Raul Herrera ◽  
Cecelia Defranco ◽  
...  

2004 ◽  
Vol 262 (4) ◽  
pp. 286-288 ◽  
Author(s):  
Isam Alobid ◽  
Llucia Al�s ◽  
Miguel Maldonado ◽  
Luis Miguel Men�ndez ◽  
Manuel Bernal-Sprekelsen

1990 ◽  
Vol 25 (11) ◽  
pp. 1152-1156 ◽  
Author(s):  
Charles E. Bagwell

Head & Neck ◽  
2000 ◽  
Vol 22 (5) ◽  
pp. 524-529 ◽  
Author(s):  
Cesare Piazza ◽  
Carmen Casirati ◽  
Giorgio Peretti ◽  
Giuseppe Battaglia ◽  
Cinzia Manfredini ◽  
...  

1992 ◽  
Vol 12 (1) ◽  
pp. 333-337
Author(s):  
Didier J. Oosterlynck ◽  
Christel Meuleman ◽  
Mark Waer ◽  
Philippe R. Koninckx

Author(s):  
C. Bianchi ◽  
N. Auzzi ◽  
I. Turrini ◽  
A. De Magnis ◽  
M. G. Fallani ◽  
...  

Abstract The purpose of this study is to evaluate the efficiency of CO2 laser colposcopic guided surgery performed in an outpatient see and treat setting in the management of VHSIL. Women with a suspected diagnosis of VHSIL and no vulvoscopic suspicion of vSCC were enrolled. An electronic register of CO2 laser treatment was created where description of performing parameters (excision or ablation) was specified and personal history was recorded. Statistical analysis was performed by Fisher’s exact test. Relative risks (RR) of risk factor were calculated and expressed in odds. From September 2014 to September 2018, we enrolled a total of 63 patients who underwent CO2 laser procedure and had a minimum follow-up time of 2 years at Careggi University Hospital in Florence. Forty-eight (76.2%) patients underwent laser excision and 15 (23.8%) patients underwent ablative treatment without histological results. Undertreatment was performed in 3 cases (6.3%) with definitive histology of vSCC. Therapeutical appropriateness of CO2 laser excision was reached in 85.4% of the cases (41/48). No volunteer loss to follow-up was registered; thus, fidelity to treatment was assess at 100%. Recurrence rate within 2 years attested in 8/60 followed patients (13.3%). No personal factor was found to influence the VHSIL course. CO2 laser excision may represent an excellent therapeutic option to VHSIL because it provides adequate oncological purpose with good cosmetic and functional results and high patients’ loyalty to treatment. An expert team could allow to undergo patients with VHSIL suspicion to unique diagnostic and therapeutic procedure with significant benefits.


1996 ◽  
Vol 17 (4) ◽  
pp. 260-263 ◽  
Author(s):  
Brendan C. Stack ◽  
Patrick J. Hall ◽  
Arnold L. Goodman ◽  
Ileana R. Perez

Sign in / Sign up

Export Citation Format

Share Document